Expertise in
4
conditions

Rodney D. Dawson

University Of Cape Town Lung Institute
Cape Town, WC, ZA 
Expertise in
4
conditions
University Of Cape Town Lung Institute
Cape Town, WC, ZA 

Overview

Rodney Dawson practices practicing medicine in Cape Town, South Africa.

Mr. Dawson is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Pulmonary Tuberculosis, Hyperferritinemia-Cataract Syndrome, HIV/AIDS, and Anorectal Abscess.

He is actively involved in clinical research, co-authoring 98 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

University of Cape Town Lung Institute
Cape Town, WC, South Africa
Other Locations
University Of Cape Town Lung Institute, Observatory, WC 7923, South Africa

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, Phase 2b/c, Open-label, Randomized, Dose-finding Trial to Evaluate the Safety and Efficacy of a 4 Month Regimen of OPC-167832 in Combination With Delamanid and Bedaquiline in Subjects With Drug-susceptible Pulmonary Tuberculosis in Comparison With Standard Treatment
A Multicenter, Phase 2b/c, Open-label, Randomized, Dose-finding Trial to Evaluate the Safety and Efficacy of a 4 Month Regimen of OPC-167832 in Combination With Delamanid and Bedaquiline in Subjects With Drug-susceptible Pulmonary Tuberculosis in Comparison With Standard Treatment
Enrollment Status: Completed
Publish Date: April 10, 2025
Intervention Type: Drug
Study Drugs: Delamanid+Bedaquiline+OPC-167832, RHEZ
Study Phase: Phase 2
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART or With Rifampin-Containing TB Treatment: The Hakim Study
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART or With Rifampin-Containing TB Treatment: The Hakim Study
Enrollment Status: Completed
Publish Date: August 21, 2023
A First Time in Human Phase 1 Open-Label Study of the Safety, Tolerability, and Immunogenicity of COVIDITY Vaccine Administered by Needle-free Intradermal Injection or Needle-free Intramuscular Injection in Healthy Adults (COVIDITY-001)
A First Time in Human Phase 1 Open-Label Study of the Safety, Tolerability, and Immunogenicity of COVIDITY Vaccine Administered by Needle-free Intradermal Injection or Needle-free Intramuscular Injection in Healthy Adults (COVIDITY-001)
Enrollment Status: Unknown
Publish Date: November 25, 2022
Intervention Type: Biological
Study Phase: Phase 1
A Phase 2 Dose-ranging Trial to Evaluate the Bactericidal Activity, Safety, Tolerability and Pharmacokinetics of Linezolid in Adult Subjects With Newly Diagnosed Drug-Sensitive, Smear-Positive Pulmonary Tuberculosis.
A Phase 2 Dose-ranging Trial to Evaluate the Bactericidal Activity, Safety, Tolerability and Pharmacokinetics of Linezolid in Adult Subjects With Newly Diagnosed Drug-Sensitive, Smear-Positive Pulmonary Tuberculosis.
Enrollment Status: Completed
Publish Date: January 11, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

82 Total Publications

Exposure-QTc modeling of bedaquiline, pretomanid, and clofazimine in adults with tuberculosis.
Exposure-QTc modeling of bedaquiline, pretomanid, and clofazimine in adults with tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: March 09, 2026

Frequently Asked Questions about Rodney D. Dawson

Is Rodney D. Dawson a top-rated expert for Pulmonary Tuberculosis?

MediFind is an objective health platform that identifies experts based on real-world data. Rodney D. Dawson is classified as an Elite expert for Pulmonary Tuberculosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rodney D. Dawson participate in research or clinical trials?

Yes. Rodney D. Dawson has published 82 articles and abstracts on conditions like Pulmonary Tuberculosis. You can view a list of Rodney D. Dawson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dawson's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile